tiprankstipranks
Coya Therapeutics, Inc. (COYA)
NASDAQ:COYA
US Market
COYA
Coya Therapeutics, Inc.
RESEARCH TOOLSreports

Coya Therapeutics, Inc. (COYA) Financial Statements

Compare
117 Followers

Coya Therapeutics, Inc. Financial Overview

Coya Therapeutics, Inc.'s market cap is currently $98.05M. The company's EPS TTM is $-0.34; its P/E ratio is -4.57; Coya Therapeutics, Inc. is scheduled to report earnings on March 16, 2026, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 7.95M$ 3.55M$ 6.00M$ 0.00$ 0.00
Gross Profit$ 7.92M$ -8.31M$ 500.68K$ -4.41M$ 0.00
Operating Income$ -20.27M$ -17.25M$ -7.90M$ -9.81M$ -4.87M
EBITDA$ -20.24M$ -17.20M$ -7.33M$ -9.26M$ -4.85M
Net Income$ -21.23M$ -14.88M$ -7.99M$ -12.24M$ -4.89M
Balance Sheet
Cash & Short-Term Investments$ 46.82M$ 38.34M$ 32.63M$ 5.93M$ 4.34M
Total Assets$ 49.95M$ 44.35M$ 41.26M$ 8.40M$ 4.79M
Total Debt$ 0.00$ 0.00$ 0.00$ 12.97M$ 0.00
Net Debt$ -46.82M$ -38.34M$ -32.63M$ 7.03M$ -4.34M
Total Liabilities$ 6.92M$ 4.77M$ 5.63M$ 16.79M$ 1.15M
Stockholders' Equity$ 43.03M$ 39.58M$ 35.64M$ -8.39M$ 3.64M
Cash Flow
Free Cash Flow$ -10.74M$ -10.29M$ -11.19M$ -7.24M$ -4.04M
Operating Cash Flow$ -10.74M$ -10.29M$ -11.19M$ -7.24M$ -3.90M
Investing Cash Flow$ -1.16M$ -25.00K$ -543.19K$ -525.00K$ -136.80K
Financing Cash Flow$ 20.39M$ 16.03M$ 38.43M$ 9.36M$ -340.58K
Currency in USD

Coya Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Coya Therapeutics, Inc. Debt to Assets

Balance Sheet >

Coya Therapeutics, Inc. Cash Flow

Cash Flow >

Coya Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >